ACETAZOLAMIDE EXTENDED-RELEASE
- Product NDC
- 42571-243
- 11-digit product format
- 425710243
- Labeler code
- 42571
- Product ID
- 42571-243_456f5ce4-6ad1-f0a1-e063-6294a90a0fac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide extended-release
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Micro Labs Limited
- Application
- ANDA207401
- Marketing category
- ANDA
- Marketing start
- 2020-12-01
- Substance
- ACETAZOLAMIDE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ACETAZOLAMIDE EXTENDED-RELEASE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 562524 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42571-243-01 | ACETAZOLAMIDE EXTENDED-RELEASE | 100 in 1 BOTTLE | CAPSULE | 100 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42571-243 | ACETAZOLAMIDE EXTENDED-RELEASE (ACETAZOLAMIDE EXTENDED-RELEASE) CAPSULE [MICRO LABS LIMITED] | 6 | Current NDC, Legacy NDC, 1 package rows | 20250112_78f78919-a6ba-4072-bc45-2ab3637ed894.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42571-243-01 | 42571024301 | 100 CAPSULE in 1 BOTTLE (42571-243-01) | 100 capsule | 2020-12-01 | 0000-00-00 | No | No | Current |